ArticleMolecular therapy. Nucleic acids2026

Bridging the antiviral gap: A BAC-based non-infectious SARS-CoV-2 replicon reveals potent antisense gapmers.

Agnieszka Ruszkowska et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.